Skip to Main Content

Paper Details

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Sci Adv
100
2021
SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 antibody, cough, fever, oxygen, plasma, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Charles Y ChiuUniversity of California san francisco
Charles Y ChiuUniversity of California san francisco
Charles Y Chiu
Philip J NorrisVitalant Research Institute
Mars StoneVitalant Research Institute
Michael P BuschUniversity of California san francisco
Michael P BuschVitalant Research Institute
James A WellsDepartment of Pharmaceutical Chemistry, University of California san francisco
James A WellsUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Timothy J HenrichUniversity of California san francisco
  • 1 - 12

Datasets

Release 1.2